Physiological Changes During Pregnancy

The human body undergoes significant physiological changes during pregnancy. The cardiovascular system experiences an increase in stroke volume by 30%, heart rate by 15%, and cardiac output by 40%. However, systolic blood pressure remains unchanged, while diastolic blood pressure decreases in the first and second trimesters, returning to non-pregnant levels by term. The enlarged uterus may interfere with venous return, leading to ankle edema, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation by 40%, with tidal volume increasing from 500 to 700 ml due to the effect of progesterone on the respiratory center. Oxygen requirements increase by only 20%, leading to over-breathing and a fall in pCO2, which can cause a sense of dyspnea accentuated by the elevation of the diaphragm. The basal metabolic rate increases by 15%, possibly due to increased thyroxine and adrenocortical hormones, making warm conditions uncomfortable for women.

The maternal blood volume increases by 30%, mostly in the second half of pregnancy. Red blood cells increase by 20%, but plasma increases by 50%, leading to a decrease in hemoglobin. There is a low-grade increase in coagulant activity, with a rise in fibrinogen and Factors VII, VIII, X. Fibrinolytic activity decreases, returning to normal after delivery, possibly due to placental suppression. This prepares the mother for placental delivery but increases the risk of thromboembolism. Platelet count falls, while white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow by 30%, with glomerular filtration rate increasing by 30-60%. Salt and water reabsorption increase due to elevated sex steroid levels, leading to increased urinary protein losses. Trace glycosuria is common due to the increased GFR and reduction in tubular reabsorption of filtered glucose.

Calcium requirements increase during pregnancy, especially during the third trimester and lactation. Calcium is transported actively across the placenta, while serum levels of calcium and phosphate fall with a fall in protein. Ionized levels of calcium remain stable, and gut absorption of calcium increases substantially due to increased 1,25 dihydroxy vitamin D.

The liver experiences an increase in alkaline phosphatase by 50%,

Supplementation Options for Nutrient Deficiencies: A Clinical Overview

Vitamin B12 Supplementation for Deficiency

Vitamin B12 is a crucial nutrient involved in the production of red blood cells. Its deficiency can cause various clinical presentations, including glossitis, jaundice, depression, psychosis, and neurological findings like subacute combined degeneration of the spinal cord. The deficiency is commonly seen in strict vegans and patients with diseases affecting the terminal ileum. Management depends on the cause, and oral supplementation is recommended for dietary causes, while intramuscular injections are indicated for malabsorption.

Folate Supplementation for Deficiency

Folate deficiency is typically seen in patients with alcoholism and those taking anti-folate medications. However, the clinical findings of folate deficiency are different from those of vitamin B12 deficiency. Patients with folate deficiency may present with fatigue, weakness, and pallor.

Magnesium Supplementation for Hypomagnesaemia

Hypomagnesaemia is commonly seen in patients with severe diarrhoea, diuretic use, alcoholism, or long-term proton pump inhibitor use. The clinical presentation of hypomagnesaemia is variable but classically involves ataxia, paraesthesia, seizures, and tetany. Management involves magnesium replacement.

Oral Steroids for Acute Exacerbations of Crohn’s Disease

Oral steroids are indicated in patients suffering from acute exacerbations of Crohn’s disease, which typically presents with abdominal pain, diarrhoea, fatigue, and fevers.

Vitamin D Supplementation for Deficiency

Vitamin D deficiency is typically seen in patients with dark skin, fatigue, bone pain, weakness, and osteoporosis. Supplementation is recommended for patients with vitamin D deficiency.

Possible Diagnoses for a Patient with Epigastric Pain and History of Cardiac Stents

Introduction:
A patient with a history of cardiac stents presents with epigastric pain. The following are possible diagnoses that should be considered.

Myocardial Infarction:
Due to the patient’s history of cardiac stents, ruling out a myocardial infarction (MI) is crucial. An electrocardiogram (ECG) should be performed early to treat any existing cardiac condition without delay.

Duodenal Ulcer:
A duodenal ulcer would have likely been visualized on an oesophagogastroduodenoscopy (OGD). However, a normal erect CXR and absence of peritonitis exclude a perforated duodenal ulcer.

Acute Gastritis:
Given the patient’s history of aspirin and NSAID use, as well as the gastric erosions visualized on endoscopy, acute gastritis is the most likely diagnosis. However, it is important to first exclude MI as a cause of the patient’s symptoms due to their history of MI and presentation of epigastric pain.

Pancreatitis:
Pancreatitis is unlikely, given the normal amylase. However, on occasion, this can be normal in cases depending on the timing of the blood test or whether the pancreas has had previous chronic inflammation.

Ischaemic Bowel:
Ischaemic bowel would present with more generalized abdominal pain and metabolic lactic acidosis on blood gas. Therefore, it is less likely to be the cause of the patient’s symptoms.

Common Causes of Diarrhoea in Immunocompromised Patients

Immunocompromised patients, particularly those with HIV infection, are at increased risk of developing chronic diarrhoea. Among the causative organisms, Cryptosporidium is the most commonly isolated. This intracellular protozoan parasite can cause severe debilitating diarrhoea with weight loss and malabsorption in HIV-infected patients. Treatment involves fluid rehydration, electrolyte correction, and pain management, with the initiation of highly active antiretroviral therapy (HAART) being crucial for restoring immunity.

Salmonella, Isospora belli, Campylobacter, and Shigella are other common causes of diarrhoea in immunosuppressed patients. Salmonella infection typically occurs after eating uncooked foods such as chicken, while Isospora species can also cause diarrhoea but not as commonly as Cryptosporidium. Campylobacter infection can present with a flu-like prodrome, fever, and in severe cases, bloody diarrhoea and severe colitis. Treatment often involves quinolones, but one complication to be wary of is the subsequent development of neurological symptoms due to Guillain–Barré syndrome. Shigella infection typically presents with bloody diarrhoea after ingestion of the toxin.

If a patient presents with menorrhagia along with pelvic pain, abnormal exam findings, or intermenstrual or postcoital bleeding, it is recommended to conduct a transvaginal ultrasound. According to the NICE guidelines, a transvaginal ultrasound should be preferred over a transabdominal ultrasound or MRI for women with significant dysmenorrhoea or a bulky, tender uterus on examination that suggests adenomyosis.

In the case of Lila, who is experiencing new menorrhagia and significant dysmenorrhoea, a transvaginal ultrasound is necessary. If a transvaginal ultrasound is not possible, a transabdominal ultrasound or MRI can be considered, but the limitations of these techniques should be explained.

For women without identified pathology, fibroids less than 3 cm in diameter, or suspected or diagnosed adenomyosis, the first-line treatment recommended by the guideline is a levonorgestrel intrauterine system (LNG-IUS). While this may be an appropriate treatment for Lila, the initial next step should be to arrange for a transvaginal ultrasound to investigate further. At this stage, there are no red flags in Lila’s history or examination that warrant an urgent referral to gynaecology.

Managing Heavy Menstrual Bleeding

Heavy menstrual bleeding, also known as menorrhagia, is a condition where a woman experiences excessive blood loss during her menstrual cycle. While it was previously defined as total blood loss of over 80 ml per cycle, the management of menorrhagia now depends on the woman’s perception of what is excessive. In the past, hysterectomy was a common treatment for heavy periods, but the approach has changed significantly since the 1990s.

To manage menorrhagia, a full blood count should be performed in all women. If symptoms suggest a structural or histological abnormality, a routine transvaginal ultrasound scan should be arranged. For women who do not require contraception, mefenamic acid or tranexamic acid can be used. If there is no improvement, other drugs can be tried while awaiting referral.

For women who require contraception, options include the intrauterine system (Mirena), combined oral contraceptive pill, and long-acting progestogens. Norethisterone can also be used as a short-term option to rapidly stop heavy menstrual bleeding.

Surgical management is recommended for all ectopic pregnancies that are larger than 35mm or have a serum B-hCG level greater than 5,000 IU/L.

Ectopic pregnancy is a serious condition that requires prompt investigation and management. Women who are stable are typically investigated and managed in an early pregnancy assessment unit, while those who are unstable should be referred to the emergency department. The investigation of choice for ectopic pregnancy is a transvaginal ultrasound, which will confirm the presence of a positive pregnancy test.

There are three ways to manage ectopic pregnancies: expectant management, medical management, and surgical management. The choice of management will depend on various criteria, such as the size of the ectopic pregnancy, whether it is ruptured or not, and the patient’s symptoms and hCG levels. Expectant management involves closely monitoring the patient over 48 hours, while medical management involves giving the patient methotrexate and requires follow-up. Surgical management can involve salpingectomy or salpingostomy, depending on the patient’s risk factors for infertility.

Salpingectomy is the first-line treatment for women without other risk factors for infertility, while salpingostomy should be considered for women with contralateral tube damage. However, around 1 in 5 women who undergo a salpingostomy require further treatment, such as methotrexate and/or a salpingectomy. It is important to carefully consider the patient’s individual circumstances and make a decision that will provide the best possible outcome.

The Edinburgh Scale is a useful tool for screening postnatal depression. The fact that the husband is bringing his wife to the GP practice a month after giving birth suggests that her mood change is not due to baby blues, which typically resolve within three days of giving birth. It is more likely that she is suffering from postnatal depression, but it is important to assess her correctly before offering any treatment such as ECT. The Edinburgh depression scale can be used to assess the patient, with a score greater than 10 indicating possible depression. If there is no immediate harm to the mother or baby, watchful waiting is usually the first step in managing this condition. There is no indication in this question that the mother is experiencing domestic abuse.

Understanding Postpartum Mental Health Problems

Postpartum mental health problems can range from mild ‘baby-blues’ to severe puerperal psychosis. To screen for depression, healthcare professionals may use the Edinburgh Postnatal Depression Scale, which is a 10-item questionnaire that indicates how the mother has felt over the previous week. A score of more than 13 indicates a ‘depressive illness of varying severity’, with sensitivity and specificity of more than 90%. The questionnaire also includes a question about self-harm.

‘Baby-blues’ is seen in around 60-70% of women and typically occurs 3-7 days following birth. It is more common in primips, and mothers are characteristically anxious, tearful, and irritable. Reassurance and support from healthcare professionals, particularly health visitors, play a key role in managing this condition. Most women with the baby blues will not require specific treatment other than reassurance.

Postnatal depression affects around 10% of women, with most cases starting within a month and typically peaking at 3 months. The features are similar to depression seen in other circumstances, and cognitive behavioural therapy may be beneficial. Certain SSRIs such as sertraline and paroxetine may be used if symptoms are severe. Although these medications are secreted in breast milk, they are not thought to be harmful to the infant.

Puerperal psychosis affects approximately 0.2% of women and requires admission to hospital, ideally in a Mother & Baby Unit. Onset usually occurs within the first 2-3 weeks following birth, and features include severe swings in mood (similar to bipolar disorder) and disordered perception (e.g. auditory hallucinations). There is around a 25-50% risk of recurrence following future pregnancies. Paroxetine is recommended by SIGN because of the low milk/plasma ratio, while fluoxetine is best avoided due to a long half-life.

The patient’s sudden rise in creatinine after stent removal suggests obstruction leading to hydronephrosis. This is the most likely diagnosis, but other possibilities include acute rejection, calcineurin toxicity, infection, or surgical complications. A renal ultrasound is needed to confirm the diagnosis and rule out other issues before a renal biopsy can be considered. Donor specific antibodies may also be tested, but a biopsy is still necessary for confirmation and treatment.

Investigations for a Patient with Stroke and Suspected Multiple Myeloma

When a patient presents with symptoms of stroke and possible multiple myeloma, several investigations may be necessary to confirm the diagnosis and determine the cause of the stroke. The mnemonic CRAB (high Calcium, Renal insufficiency, Anaemia and Bone lesions) can help identify the key symptoms of multiple myeloma.

One potential test is a urinary Bence Jones protein test, which can confirm the presence of multiple myeloma. However, this test alone cannot determine the cause of the stroke.

An MRI of the head may show areas of damage, but it will not reveal the cause of the stroke. A CT scan of the head, on the other hand, can identify changes caused by an ischaemic stroke, but it cannot differentiate the cause of the clot.

Liver function tests and X-rays of the spine are not first-line investigations for this condition, but they may be useful in identifying bone lesions associated with multiple myeloma.

Overall, a combination of tests and imaging may be necessary to diagnose and treat a patient with stroke and suspected multiple myeloma.

Bendroflumethiazide, a thiazide-like diuretic, is prescribed as a third-line treatment for hypertension. However, it can increase the risk of digoxin toxicity when taken with digoxin. Symptoms of digoxin toxicity include nausea, vomiting, confusion, weakness, palpitations, and can lead to serious complications such as hyperkalaemia, arrhythmias, and cardiac arrest. Dabigatran, a direct thrombin inhibitor, is a potential medication for stroke prophylaxis in patients with atrial fibrillation, but it does not cause digoxin toxicity. Flecainide, an anti-arrhythmic agent, can cause bradycardia when taken with digoxin, but it is not likely to cause digoxin toxicity. Furosemide, a loop diuretic, is not indicated for hypertension or atrial fibrillation and is not the most likely cause of digoxin toxicity in this patient who has no signs of fluid overload.

Understanding Digoxin and Its Toxicity

Digoxin is a medication used for rate control in atrial fibrillation and for improving symptoms in heart failure patients. It works by decreasing conduction through the atrioventricular node and increasing the force of cardiac muscle contraction. However, it has a narrow therapeutic index and requires monitoring for toxicity.

Toxicity may occur even when the digoxin concentration is within the therapeutic range. Symptoms of toxicity include lethargy, nausea, vomiting, anorexia, confusion, yellow-green vision, arrhythmias, and gynaecomastia. Hypokalaemia is a classic precipitating factor, as it allows digoxin to more easily bind to the ATPase pump and increase its inhibitory effects. Other factors that may contribute to toxicity include increasing age, renal failure, myocardial ischaemia, electrolyte imbalances, hypoalbuminaemia, hypothermia, hypothyroidism, and certain medications such as amiodarone, quinidine, and verapamil.

Management of digoxin toxicity involves the use of Digibind, correction of arrhythmias, and monitoring of potassium levels. It is important to recognize the potential for toxicity and monitor patients accordingly to prevent adverse outcomes.

Calculating the Number Needed to Treat (NNT)

The Number Needed to Treat (NNT) is a measure used in clinical trials to determine how many patients need to be treated in order to prevent one additional bad outcome (such as a heart attack or stroke). To calculate the NNT, you first need to determine the absolute risk reduction (ARR), which is the difference in the risk of bad outcomes between the treated group and the control group. This can be calculated by subtracting the absolute risk in the treated group (ART) from the absolute risk in the control group (ARC). Once you have the ARR, you can calculate the NNT by taking the reciprocal of the ARR. An overestimation or underestimation of the NNT can occur if the absolute risk in the treated or control group is miscalculated.

Treatment Options for Subdural Haemorrhage: Burr Hole Drainage, Mannitol, Nimodipine, Endovascular Coiling, and Aspirin

Subdural haemorrhage is a serious medical condition that requires prompt treatment. The most common treatment option for subdural haemorrhage is burr hole drainage, which involves removing the haematoma and relieving the compression of the brain. Mannitol is another treatment option that is used to reduce intracranial pressure if signs of intracranial pressure are present. Nimodipine is used in cases of subarachnoid haemorrhage to reduce vasospasm, which is often an acute complication of subarachnoid haemorrhage and leads to cerebral ischaemia. Endovascular coiling is a treatment for subarachnoid haemorrhage and is not indicated for subdural haemorrhage. Aspirin is contraindicated in the case of a haemorrhagic stroke or intracranial haemorrhage, as it can worsen bleeding. Therefore, it is important to rule out bleeding as the cause of the patient’s symptoms before administering aspirin.

Medication-Induced Complications: Common Side Effects to Watch Out For

Alendronate: A rare complication of bisphosphonate therapy, osteonecrosis of the jaw is identified by non-healing gingival lesions, with exposure of mandible or maxilla bone, and patients may present with pain and secondary infection. Treatment is often conservative, with analgesia and infection control, although some patients require debridement.

Bisoprolol: Beta-blockers may cause bradycardia, bronchospasm, and Raynaud’s phenomenon.

Carbamazepine: This medication may cause cardiac arrhythmias, visual changes, and agranulocytosis.

Doxycycline: Tetracyclines are related to staining of the teeth in children and phototoxicity that requires the patient to wear high-factor sunblock.

Phenytoin: Gingival hyperplasia and inflammation may be caused by phenytoin.

It is important to consider that with any presentation to hospital, particularly less usual symptoms or signs, that medications may be a cause.

Neurological Lesions and Their Effects on Motor Function: An Overview

The human body relies on a complex network of nerves to control movement. When these nerves are damaged, it can result in a variety of motor function impairments. Two types of nerve lesions are upper motor neurone and lower motor neurone lesions.

Upper motor neurone lesions affect the corticospinal tract, which connects the primary motor cortex to the alpha motor neurones in the spinal cord. This type of lesion causes spasticity, hyperreflexia, pyramidal weakness, clasp-knife rigidity, and extensor plantar responses.

Lower motor neurone lesions affect the alpha motor neurone and can occur anywhere along the path of the final nerve, from the spinal cord to the peripheral nerve. This type of lesion causes muscle weakness, wasting, hyporeflexia, and fasciculations.

Other nerve lesions can also affect motor function. Vagus nerve palsy, for example, can result in palatal weakness, nasal speech, loss of reflex contraction in the gag reflex, hoarseness of the voice, and a bovine cough. A plexiform neuroma, a benign tumor of the peripheral nerves, can cause a lower motor neurone lesion.

Understanding the effects of neurological lesions on motor function is crucial for diagnosing and treating these conditions.

Managing Bony Pain in Patients with Metastatic Carcinoma

The common assumption is that all bony pain in patients with metastatic carcinoma is solely due to bone metastases. However, it is important to consider other possible causes, especially if the pain is worsened by movement and has a different character from known bone metastases. Patients with advanced malignancy are prone to low-force fractures, particularly in the neck of the humerus, even without a history of trauma.

Before increasing opioid dosage or adding NSAIDs, it is crucial to confirm the diagnosis and immobilize the fracture site. A broad arm sling can often provide sufficient pain relief. Bisphosphonates should not be used unless hypercalcemia has been confirmed. When a fracture is suspected, an x-ray is a simpler investigation modality than a bone scan or MRI. However, an MRI may be necessary to provide detail if a pathological fracture requires surgical repair, such as a neck of femur fracture associated with metastatic deposit.

While dexamethasone can be used as an adjunct in pain management, it should not be the next step. Proper diagnosis and immobilization of the fracture site should be the primary focus in managing bony pain in patients with metastatic carcinoma.

Salicylate overdose typically results in a combination of primary respiratory alkalosis and metabolic acidosis. The overdose triggers hyperventilation and respiratory alkalosis by directly stimulating the cerebral medulla. As aspirin is broken down, it disrupts ATP synthesis by uncoupling oxidative phosphorylation in the mitochondria. This leads to an increase in lactate levels due to anaerobic metabolism, which, along with salicylate metabolites, causes metabolic acidosis. Metabolic acidosis is also commonly caused by severe diarrhoea, renal failure, and diabetic ketoacidosis. On the other hand, metabolic alkalosis is often caused by vomiting, nasogastric suctioning, hypokalemia, and antacid use. Respiratory acidosis is frequently caused by COPD, obesity, pneumonia, and respiratory muscle weakness, while respiratory alkalosis can be caused by hyperventilation, anaemia, or drug-induced stimulation of the respiratory centre. In the case of salicylate overdose, respiratory alkalosis is the primary cause of the mixed acid-base disorder, but it also contributes to metabolic acidosis.

Salicylate overdose can result in a combination of respiratory alkalosis and metabolic acidosis. The initial effect of salicylates is to stimulate the respiratory center, leading to hyperventilation and respiratory alkalosis. However, as the overdose progresses, the direct acid effects of salicylates, combined with acute renal failure, can cause metabolic acidosis. In children, metabolic acidosis tends to be more prominent. Other symptoms of salicylate overdose include tinnitus, lethargy, sweating, pyrexia, nausea/vomiting, hyperglycemia and hypoglycemia, seizures, and coma.

The treatment for salicylate overdose involves general measures such as airway, breathing, and circulation support, as well as administering activated charcoal. Urinary alkalinization with intravenous sodium bicarbonate can help eliminate aspirin in the urine. In severe cases, hemodialysis may be necessary. Indications for hemodialysis include a serum concentration of salicylates greater than 700 mg/L, metabolic acidosis that is resistant to treatment, acute renal failure, pulmonary edema, seizures, and coma.

It is important to note that salicylates can cause the uncoupling of oxidative phosphorylation, which leads to decreased adenosine triphosphate production, increased oxygen consumption, and increased carbon dioxide and heat production. Therefore, prompt and appropriate treatment is crucial in managing salicylate overdose.

In the case of a young girl seeking emergency contraception, it is important to consider her age and ability to consent to sexual activity. If she is under 13 years old, sexual intercourse with her partner would be considered statutory rape and child protection measures must be taken immediately. It is important to consult with a general practitioner safeguarding lead or designated doctor for child protection, make an urgent social services referral, and inform the police. If the girl is deemed Fraser-competent, emergency contraception can be provided without necessarily involving her parents, but she should be encouraged to involve them in decision-making. It is crucial to prioritize the girl’s safety and well-being by providing emergency contraception and taking necessary child protection measures. Contacting the girl’s parents without her consent may damage the trust between the doctor and patient and delay necessary action.

Gestational hypertension is a condition where a woman develops high blood pressure after 20 weeks of pregnancy, without significant protein in the urine. This woman has moderate gestational hypertension, with her systolic blood pressure ranging between 150-159 mmHg and diastolic blood pressure ranging between 100-109 mmHg.

Typically, moderate gestational hypertension does not require hospitalization and can be treated with oral labetalol. However, as this woman has a history of asthma, labetalol is not recommended. Instead, NICE guidelines suggest nifedipine or methyldopa as alternatives. Methyldopa is not recommended for patients with depression, so the best option for this woman is oral nifedipine, which is a calcium channel blocker.

In cases of eclampsia, IV magnesium sulphate is necessary. It’s important to note that lisinopril, an ACE inhibitor, is not safe for use during pregnancy.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

Alcohol can affect the way many drugs are metabolized and can alter their bioavailability. Chronic alcohol excess can cause a paradoxical induction in the cytochrome P450 enzyme system, leading to a relative reduction in bioavailability of drugs that utilize this metabolism pathway. Atorvastatin and other drugs of this class can have altered bioavailability when used with alcohol. Metronidazole can cause a disulfiram-like reaction when mixed with alcohol. Paracetamol and metformin have few interactions with alcohol but should be closely monitored in alcoholic patients.

An isolated fever in a patient without any other symptoms within the first 24 hours following surgery is most likely a physiological response to the operation. The body produces pro-inflammatory cytokines after surgery, which can cause a systemic inflammatory immune response and result in fever. It is unlikely to be a new infectious disease if the fever occurs within 48 hours of surgery. Other potential causes such as cellulitis, post-operative pneumonia, venous thromboembolism, and urinary tract infection are less likely based on the absence of relevant symptoms.

Post-operative pyrexia, or fever, can occur after surgery and can be caused by various factors. Early causes of post-op pyrexia, which typically occur within the first five days after surgery, include blood transfusion, cellulitis, urinary tract infection, and a physiological systemic inflammatory reaction that usually occurs within a day following the operation. Pulmonary atelectasis is also often listed as an early cause, but the evidence to support this link is limited. Late causes of post-op pyrexia, which occur more than five days after surgery, include venous thromboembolism, pneumonia, wound infection, and anastomotic leak.

To remember the possible causes of post-op pyrexia, it is helpful to use the memory aid of the 4 W’s: wind, water, wound, and what did we do? (iatrogenic). This means that the causes can be related to respiratory issues (wind), urinary tract or other fluid-related problems (water), wound infections or complications (wound), or something that was done during the surgery or post-operative care (iatrogenic). It is important to identify the cause of post-op pyrexia and treat it promptly to prevent further complications. This information is based on a peer-reviewed publication available on the National Center for Biotechnology Information website.

The British Thoracic Society guidelines should be followed for managing acute asthma, with patients stratified into moderate, severe, or life threatening categories. This patient has life threatening features and may require anaesthetic intervention for intubation and ventilation. Magnesium sulphate is the next important drug intervention. Adrenaline nebulisers have no role unless there are signs of upper airway obstruction. Aminophylline infusions are no longer recommended for initial stabilisation. Salbutamol inhalers can be used as a rescue measure in moderate exacerbations but have no role in severe or life threatening cases. Both prednisone and hydrocortisone are equally effective for steroid treatment.

Diagnostic Tests for Coeliac Disease

Coeliac disease is a condition that affects the small intestine and is caused by an intolerance to gluten. There are several diagnostic tests available to help establish a diagnosis of coeliac disease. The first line test is the IgA tissue transglutaminase (tTGA) antibody serology. A positive test indicates that further testing, such as endoscopy and biopsy, is needed for confirmation.

Before testing, it is important to confirm that the patient has been consuming gluten-containing foods regularly for at least six weeks. HLA testing is not a first line test and should only be carried out in secondary care.

If the tTGA test is unavailable or weakly positive, IgA endomysial antibody testing may be used as a second line test. Small bowel biopsy is only indicated if serology is positive or equivocal.

There is no indication for an abdominal CT scan in this scenario. The first line investigation for coeliac disease is serology, and if positive, diagnosis is confirmed or excluded by biopsy of the small bowel at endoscopy.

This type of lesion, which appears crusty and causes tears, is typically associated with Paget’s disease of the nipple. It is worth noting that the areolar region is usually unaffected. While there may not be a palpable mass, some patients may still have an invasive cancer underlying the lesion, which can lead to lymphadenopathy.

Paget’s disease of the nipple is a condition that affects the nipple and is associated with breast cancer. It is present in a small percentage of patients with breast cancer, typically around 1-2%. In half of these cases, there is an underlying mass lesion, and 90% of those patients will have an invasive carcinoma. Even in cases where there is no mass lesion, around 30% of patients will still have an underlying carcinoma. The remaining cases will have carcinoma in situ.

One key difference between Paget’s disease and eczema of the nipple is that Paget’s disease primarily affects the nipple and later spreads to the areolar, whereas eczema does the opposite. Diagnosis of Paget’s disease involves a punch biopsy, mammography, and ultrasound of the breast. Treatment will depend on the underlying lesion causing the disease.

Treatment Approach for Shared Delusional Disorder

Shared delusional disorder, also known as folie à deux, is a rare psychiatric condition where two individuals develop a paired delusion. In cases where one of the individuals has a history of psychiatric illness, separating the patients is the first step in treating the disorder. This is because the dominant force in the duo may be the source of the delusion, and separating them may resolve the delusion in the other individual.

While benzodiazepines can sedate the patients, they will not acutely reverse psychosis. Similarly, selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) are not indicated as they take time to work and are not effective in acutely reversing psychosis.

Cognitive behavioural therapy (CBT) is a treatment approach that takes time and is not effective in acutely reversing psychosis in either of the patients. Therefore, in cases of shared delusional disorder, separating the patients and providing anti-psychotic therapy to the dominant individual may be the most effective treatment approach.

Tamoxifen is the preferred treatment for premenopausal women with oestrogen receptor-positive breast cancer. It is a selective oestrogen receptor modulator (SERM) that partially antagonizes the oestrogen receptor. Other options for endocrine therapy include aromatase inhibitors and GnRH agonists, but these are not typically used as first-line treatment for premenopausal women with breast cancer. GnRH antagonists and complete antagonists of the oestrogen receptor are not used in the management of breast cancer.

Anti-oestrogen drugs are used in the management of oestrogen receptor-positive breast cancer. Selective oEstrogen Receptor Modulators (SERM) such as Tamoxifen act as an oestrogen receptor antagonist and partial agonist. However, Tamoxifen can cause adverse effects such as menstrual disturbance, hot flashes, venous thromboembolism, and endometrial cancer. On the other hand, aromatase inhibitors like Anastrozole and Letrozole reduce peripheral oestrogen synthesis, which is important in postmenopausal women. Anastrozole is used for ER +ve breast cancer in this group. However, aromatase inhibitors can cause adverse effects such as osteoporosis, hot flashes, arthralgia, myalgia, and insomnia. NICE recommends a DEXA scan when initiating a patient on aromatase inhibitors for breast cancer.

If a person has G6PD deficiency, they should not take ciprofloxacin as it can cause haemolytic reactions. Other antibiotics are safe to use, but nitrofurantoin, chloramphenicol, and sulfonamides also have a high risk of causing haemolysis. For treating acute prostatitis in this man, trimethoprim would be the recommended empirical antibiotic according to NICE guidelines if a quinolone is not an option.

Understanding Quinolones: Antibiotics that Inhibit DNA Synthesis

Quinolones are a type of antibiotics that are known for their bactericidal properties. They work by inhibiting DNA synthesis, which makes them effective in treating bacterial infections. Some examples of quinolones include ciprofloxacin and levofloxacin.

The mechanism of action of quinolones involves inhibiting topoisomerase II (DNA gyrase) and topoisomerase IV. However, bacteria can develop resistance to quinolones through mutations to DNA gyrase or by using efflux pumps that reduce the concentration of quinolones inside the cell.

While quinolones are generally safe, they can have adverse effects. For instance, they can lower the seizure threshold in patients with epilepsy and cause tendon damage, including rupture, especially in patients taking steroids. Additionally, animal models have shown that quinolones can damage cartilage, which is why they are generally avoided in children. Quinolones can also lengthen the QT interval, which can be dangerous for patients with heart conditions.

Quinolones should be avoided in pregnant or breastfeeding women and in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Overall, understanding the mechanism of action, mechanism of resistance, adverse effects, and contraindications of quinolones is important for their safe and effective use in treating bacterial infections.

When a person experiences acute upper urinary tract obstruction, the recommended course of action is to undergo nephrostomy. In this case, it is likely that the obstruction was caused by a calculus or stone in the ureter. If left untreated, the stagnant urine can become infected, which is considered a serious urological emergency. Since the stone cannot be removed, a nephrostomy is necessary.

Hydronephrosis is a condition where the kidney becomes swollen due to urine buildup. There are various causes of hydronephrosis, including pelvic-ureteric obstruction, aberrant renal vessels, calculi, tumors of the renal pelvis, stenosis of the urethra, urethral valve, prostatic enlargement, extensive bladder tumor, and retroperitoneal fibrosis. Unilateral hydronephrosis is caused by one of these factors, while bilateral hydronephrosis is caused by a combination of pelvic-ureteric obstruction, aberrant renal vessels, and tumors of the renal pelvis.

To investigate hydronephrosis, ultrasound is the first-line test to identify the presence of hydronephrosis and assess the kidneys. IVU is used to assess the position of the obstruction, while antegrade or retrograde pyelography allows for treatment. If renal colic is suspected, a CT scan is used to detect the majority of stones.

The management of hydronephrosis involves removing the obstruction and draining urine. In cases of acute upper urinary tract obstruction, a nephrostomy tube is used, while chronic upper urinary tract obstruction is treated with a ureteric stent or a pyeloplasty. The CT scan image shows a large calculus in the left ureter with accompanying hydroureter and massive hydronephrosis in the left kidney.

Overall, hydronephrosis is a serious condition that requires prompt diagnosis and treatment to prevent further complications.

Glomerular Proteinuria

Although a small amount of protein is typically found in urine, an elevated level of protein indicates a potential health issue. The diagram below illustrates the various sources of protein in urine, with glomerular proteinuria being the likely cause in this case due to the presence of larger proteins. This type of proteinuria can result in significant loss of protein through urine. It is important to identify the underlying cause of glomerular proteinuria and seek appropriate medical treatment to prevent further damage to the kidneys. Proper management can help reduce the risk of complications and improve overall health outcomes.

Understanding the Role of Apolipoprotein E Gene Alleles in Alzheimer’s Disease and Cardiovascular Risk

Apolipoprotein E (ApoE) is a crucial component of very low-density lipoprotein (VLDL) and has three common gene alleles: ApoE-e2, e3, and e4. Among these, e3 is the most prevalent, found in 50% of the population. However, the presence of different alleles can have varying effects on an individual’s health.

ApoE-e2 is considered a protective gene against the development of Alzheimer’s disease. On the other hand, ApoE-e4 is regarded as a positive predictor for developing the disease and is also associated with the development of atheromatous disease, making it a predictor of cardiovascular risk.

It is important to note that ApoE-e1 and e5 are not significant in terms of their association with Alzheimer’s disease or cardiovascular risk. Therefore, understanding the role of ApoE gene alleles can help in predicting an individual’s susceptibility to these diseases and developing appropriate preventive measures.

Chlamydia trachomatis is the most common cause of acute epididymo-orchitis in sexually active young adults. This patient’s symptoms and signs are consistent with epididymo-orchitis, and the timing suggests this diagnosis over testicular torsion. While mumps can also cause epididymo-orchitis, it is less common and not supported by the absence of other symptoms. In men over 35 years old, E. coli is the most common cause, but given this patient’s age and sexual history, chlamydia is the most likely culprit. Neisseria gonorrhoeae is the second most common cause in this age group.

Epididymo-orchitis is a condition where the epididymis and/or testes become infected, leading to pain and swelling. It is commonly caused by infections spreading from the genital tract or bladder, with Chlamydia trachomatis and Neisseria gonorrhoeae being the usual culprits in sexually active younger adults, while E. coli is more commonly seen in older adults with a low-risk sexual history. Symptoms include unilateral testicular pain and swelling, with urethral discharge sometimes present. Testicular torsion, which can cause ischaemia of the testicle, is an important differential diagnosis and needs to be excluded urgently, especially in younger patients with severe pain and an acute onset.

Investigations are guided by the patient’s age, with sexually transmitted infections being assessed in younger adults and a mid-stream urine (MSU) being sent for microscopy and culture in older adults with a low-risk sexual history. Management guidelines from the British Association for Sexual Health and HIV (BASHH) recommend ceftriaxone 500 mg intramuscularly as a single dose, plus doxycycline 100 mg orally twice daily for 10-14 days if the organism causing the infection is unknown. Further investigations are recommended after treatment to rule out any underlying structural abnormalities.